ABLEnews Extra "Mistakes Will Be Made" [The following file may be freq'd as MAL50403.TXT from 1:275/14; and other BBSs that carry the ABLEFiles Distribution Network (AFDN) and ftp'd from ftp.icdi.wvu.edu on the Internet. Please allow a few days for processing.] A DEATH AT A BOSTON HOSPITAL RAISES THE QUESTION, ARE FRAZZLED DOCTORS MAKING TOO MANY FATAL MISTAKES? If anyone knew how to get the best medical treatment, it was Betsy Lehman. A health columnist who had worked at the Boston Globe since 1982, she had covered everything from leading-edge research to the finer points of a physician's bedside manner. When she learned she had an advanced case of breast cancer, she carefully studied her options and chose to undergo an experimental treatment offered at the Dana-Farber Cancer Institute, a prestigious hospital affiliated with Harvard Medical School. Tragically, the 39-year-old mother of two died in December. But as a front-page story in the Globe disclosed last week, her death was not the result of her disease. The cause was a huge overdose of a powerful anticancer drug accidentally administered by the hospital's staff. Lehman's case is just one of a spate of medical foul-ups that have made headlines in recent weeks. In two Florida incidents, a doctor amputated the wrong foot of a diabetic man, and a hospital worker mistakenly turned off a stroke victim's breathing machine. In Michigan a surgeon doing a mastectomy removed a woman's healthy breast instead of the diseased one. Are these isolated, if horrifying, events? Or could they be harbingers of a deadly trend? Though no statistical evidence shows that malpractice is on the rise, state licensing boards have stepped up their investigations of doctors. According to Public Citizen's Health Research Group, the number of physicians who have had their licenses revoked, suspended or restricted rose from 1,974 in 1992 to 2,190 in 1993, an 11% increase. Still under intense investigation, Lehman's death appears to have resulted from a mathematical error that wasn't discovered until February, when two clerks undertook a routine review of her case. As thousands of cancer patients know well, standard chemotherapy involves figuring out a treatment that is aggressive enough to destroy a tumor without also killing the patient. For each person, doctors must calculate how much drug to use in relation to the individual's size and body weight. Once malignant cells have spread beyond their original location, however, traditional chemotherapy is usually much less successful at producing a cure. In an attempt to develop a treatment for these more advanced cases, the researchers at Dana-Farber have been experimenting with levels of antitumor agents that are much higher than those normally prescribed. In Lehman's case, the treatment was to last four days, and the amount given during each 24-hour period was supposed to be barely shy of lethal. The physician in charge of figuring out her daily dosage, whose identity has not been released, apparently made the mistake of writing down the amount that should have been given over the whole four-day period. Still, all hospitals double-check the dosage of chemotherapy drugs that are given to a patient - and Dana-Farber is no exception. According to Gina Vild, a hospital spokeswoman, once the physician has written the order, Dana-Farber's rules require two pharmacists to verify it. "Pharmacist 1 is supposed to check it and, yes, is supposed to make the calculations himself," she told Time. He then "gives it to Pharmacist 2, who looks at it and checks it" before sending the drug to the patient's room. When the order for Lehman came through, neither pharmacist caught the mistake in dosage. Even at the bedside, there was still a chance for someone to realize that something had gone desperately wrong. Lehman's blood tests showed abnormal readings, and her electrocardiogram indicated enormous stresses on her heart. "She was vomiting sheets of tissue," her husband Robert Distel told the Globe. "((The doctors)) said this was the worst they had ever seen." But they considered Lehman's violent reaction to be normal for such an aggressive treatment. All told, at least five hospital staff members failed to figure out that their therapy was killing her. Dana-Farber has acknowledged full responsibility for Lehman's death, as well as the permanent heart damage of another woman who managed to survive an identical fourfold overdose. In addition to ordering an exhaustive investigation, the hospital's top physician has mandated additional precautions against such egregious mistakes. Staff members have been reassigned, and the pharmacy's computer program has been modified so that drugs cannot be dispensed over preset limits. Unfortunately, as long as doctors are human, treatment blunders can never be eliminated entirely. "With 4 million patients a day visiting physicians, it's inevitable if inexcusable that mistakes will be made," says Dr. James Todd of the American Medical Association. Three large studies over the past 30 years have documented a distressingly consistent rate of medical mishaps in the U.S. By one measure, such negligence in American hospitals may result in 80,000 deaths each year. That toll is a sign to some critics that improvement is needed in the systems that hospitals use to catch errors and review doctors' performance. "You would not walk on an airplane if you did not know that there are safety checks and backups and backups of the backups," says Dr. Sidney Wolfe, head of the Health Research Group. Hospitals need just as many fail-safe mechanisms, he says, "so that even if one or two fail, the third one catches the mistake." In some fatal cases, it is hard to know if malpractice was involved. Even the most routine procedures can go awry, whether or not doctors are at fault. New York City was stunned last week by the news that a four-year-old girl had died following a tonsillectomy, an operation that is almost never deadly. Like 100,000 other Americans each year, Desiree Wade was sent home a few hours after the surgery, which was performed at St. Luke's hospital in Manhattan. She developed a fever and became increasingly sick. Her coughs apparently tore open the surgical wounds in her throat, and she bled to death. There is no evidence that the surgeon did anything wrong, but state health officials are investigating whether the child received the proper follow-up care. If a tonsillectomy can go bad, imagine all the things that can happen with a bone-marrow transplant, a coronary-bypass operation or an experiment in gene therapy. As medicine has become more complex and the pace of technological change has accelerated, the opportunities for error have multiplied. And when doctors are constantly testing new treatments, as they are at Dana-Farber, they cannot fall back on years of experience. Factor in the new pressure to control costs, and doctors are in a real bind. The medical profession sees increased danger in the new era of managed care, in which hospitals and clinics must treat more patients more quickly with smaller staffs. "In the rush for cost containment, the caliber of the health-care team may be decreasing," warns the A.M.A.'s Todd. The challenge ahead will be to deliver care at a reasonable price without compromising safety. Perhaps the only benefit of highly publicized cases like Betsy Lehman's is that they will spur hospitals to strengthen the safeguards needed to keep such tragedies as uncommon as possible. [The Disturbing Case of the Cure That Killed the Patient, Christine Gorman, Time April 3, 1995; reported by Lawrence Mondi and Alice Park/New York and Rod Paul/Boston] CURE Comment: While, as patient advocates, we heartily concur that improvements in the quality of medical care is needed, e.g., more reasonable schedules for medical residents, we would also note that with the cancerous growth of managed-NONcare, this is not the time to strip patients and their families of the protections of malpractice laws under the guise of "tort reform." Brought to you as a public service by ABLEnews. A Fidonet-backbone echo featuring disability/medical news and information, ABLEnews is carried by more than 500 BBSs in the US, Canada, Australia, Great Britain, Greece, New Zealand, and Sweden. Available from Fidonet and Planet Connect, ABLEnews is gated to the ADANet, FamilyNet, and World Message Exchange networks. (Additional gating welcome on request.) ABLEnews text files--including our digests Of Note and MedNotes (suitable for bulletin use) are disseminated via the ABLEFile Distribution Network, available from the filebone, Planet Connect, and ftp.icdi.wvu.edu. ...For further information, contact CURE, 812 Stephen St., Berkeley Springs, WV 25411. 304-258-LIFE/258-5433 CUREltd@ix.netcom.com